In Vivo Therapeutics Policies & Procedures
Request for services
To request mice from the on-site breeding facility, fill out the appropriate online mouse request form. Contact Karen Pollok (email@example.com) for detailed information on in vivo services and pricing or to set up a consultation and study design meeting.
Select the appropriate form below:
The core is funded, in part, by grants and contracts of the investigators who utilize the facility. All IUSCC members receive discounted rates. Due to the variety of in vivo models and drug regimens requested, the specific costs of a study will be calculated once the study design is finalized.
Acknowledgment, authorship, collaboration
All research work performed by the IVT core should be acknowledged in all ensuing publications. Fees paid for services provided by the core should not negate the potential of co-authorship by core scientists. These acknowledgements and achievements are important for the existence and continued funding of the core facility. Given that many validation procedures require advanced intellectual involvement by the core’s scientists (examples listed below), it is expected that this acknowledgement will be in the form of co-authorship according to the guidelines for authorship recommended by the International Committee of Medical Journal Editors.
IVT scientists performing one or more of the following tasks meet the criteria for authorship:
- Literature review and providing assistance in selecting/conceiving the experiments appropriate for the study goals
- Experimental design
- Assay development/optimization
- Data analysis and interpretation of data, or both
- Preparation of pertinent sections/figures for the manuscript and revisions to address reviewer concerns/questions
All contributions that do not meet the criteria for authorship should be listed in the acknowledgments section. Examples of the tasks requiring an appropriate mention in the acknowledgment section are:
- Mere collection of data (e.g., Flow cytometry) using PI-provided protocols that require no further optimization and/or trouble-shooting.
- Mere collection of in vivo study data (no data analysis or interpretation by core scientists.
- Irradiation and/or transplant of bone marrow cells
- Routine sample processing (e.g., serum/plasma separation, isolation of PBMCs from blood)
Distribution of mice for studies not implemented by core personnel:
- If using mice bred by our facility, please include the following acknowledgement: Mice were obtained from the on-site breeding colony maintained by the In Vivo Therapeutics Core of the Indiana University Melvin and Bren Simon Cancer Center
- Strains we maintain:
NSG: NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
Boy J: B6.SJL-Ptprca Pepcb/BoyJ
C57BL/6J x B6.SJL-Ptprca Pepcb/BoyJ
NOD.Cg-Prkdcscid Il2rgtm1Wjl Tg(CMV-IL3,CSF2,KITLG)1Eav/MloySzJ
Mx-Cre x r26YFP
Lyz-Cre x r26YFP
Confidentiality: Data generated by the Core is kept on a secure server with access to core personnel only. Communication of data to clients will be done using a secure website on the IUSCC intranet. Each lab's folder is password protected and accessed only by lab and core personnel. Data or information (verbal and/or electronic) are not shared with any outside parties.
Conflict resolution: If a resolution cannot be reached at the core director level, the issue will be taken to the core advisory committee for discussion and resolution.
Cost recovery/payment policy: If recovery of payment becomes an issue, the IUSCC business managers will contact the customer and/or their department to collect charges owed. If there is a dispute in charges, the conflict resolution policy above will be followed.
Prioritization of work: Core studies or services will be prioritized based on IUSCC and/or IUSM membership followed by non members. Projects enter the Core upon receipt of a study request form and approved animal study or amendment. In the event that there is a back-log of studies, services will be prioritized based on IU Simon Cancer Center and/or IU School of Medicine membership followed by non-members. Priority will be given to users with peer-reviewed grant funding.
|Service||IUSCC Member and/or IUSM Rates FY 2013|
|Hourly rate services:|
|Tissue Culture Fees||$35/hour|
|Tissue Culture Supply Fees||$5/hour|
|Experimental Technique Training||$35/hour|
|Cost analysis & billing||$35/hour|
|Draft & submit study amendments||$35/hour|
|Drug Formulation (15 min increments)||$35/hour|
|"Services only" coordination charge of 1 hour per 12 mice||$35|
|Boy J mice||$22.00/mouse|
|C57 / Boy J F1||$22.00/mouse|
|Biohazard mouse room per diems||$0.94 / cage / day|
|Conventional mouse room per diems||$0.72 / cage / day|
|Data entry, analysis & graphing||$70/week of study|
|Irradiation prior to experiment||$35/hour|
|Irradiation of cells||$35/hour|
|Irradiation “late” fee if >15 minutes late (with no written notice in advance)||$35 per occurrence|
|Mycoplasma testing cell line (required for invivo studies)||$45.00/cell line|
|Tattoo fees (animal identification)||$2.00/mouse|
|Inhalation anesthesia fees (per hr-to cover O2, isoflurane)||$10/hour|
|Palpate for tumors||$1.10/mouse|
|IP, ID, or IM injection||$2.20/mouse|
|Complete Blood Count (CBC)||$11.00/mouse|
|Survival or terminal bleed||$5.50/mouse|
|Cellularity & Progenitor||$52.00/mouse **|
|Analysis (BM or spleen)||$454/bottle|
|** Methylcellulose cost not included||27 animals/bottle|
|Hematopoietic Progenitor Analysis||$34/drug treatment|
|Euthanize + Gross necropsy||$11.00/mouse|
|Euthanize + Tumor (fixation)||$11.00/mouse|
|Weekend rates will be 2 times the regular procedure rate, with minimum charge per trip ($158)|